DUBLIN--(BUSINESS WIRE)--The "Epigenetics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
Epigenetics market worldwide is projected to grow by US$16.1 Billion, driven by a compounded growth of 20.3%.
Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 20.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$9.3 Billion by the year 2025, Reagents will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 21.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$609.5 Million to the region's size and clout in the next 5 to 6 years. Over US$770.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Reagents will reach a market size of US$654.6 Million by the close of the analysis period.
As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 19.9% over the next couple of years and add approximately US$2.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.
All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- Abcam PLC
- Active Motif, Inc.
- Diagenode SA
- Eisai Co., Ltd.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Novartis International AG
- Oncolys BioPharma Inc.
- QIAGEN GmbH
- Syndax Pharmaceuticals, Inc.
- Thermo Fisher Scientific, Inc.
- Valirx Plc
Zymo Research Corporation
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Product Overview
- Epigenetics: A Prelude
- US to Dominate the Epigenetics Market
- Global Competitor Market Shares
- Epigenetics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prominence of Epigenetics Led Diagnostics
- New Innovations and Techniques in Epigenetics
- New Epigenetics Research Findings Creating Problems
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/duoci